BACKGROUND |
1
Introduction to Lipids and Lipoproteins
|
Kenneth R. Feingold, MD |
2
The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders
|
Ernst J Schaefer, Fumiyoshi Tsunoda, Margaret Diffenderfer, Eliana Polisecki, Ngoc Thai and Bela Asztalos |
3
Utility of Advanced Lipoprotein Testing in Clinical Practice
|
Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD |
4
The Role of Lipids and Lipoproteins in Atherosclerosis
|
MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA, Wenliang L. Song, MD, Amanda C. Doran, PhD, MD and Kasey C. Vickers, PhD |
5
Guidelines for the Management of High Blood Cholesterol
|
Scott M. Grundy, MD and Kenneth R. Feingold, MD |
6
Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis
|
Deval Bhatt, M.D. and Lisa Tannock, MD |
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM |
7
Familial Hypercholesterolemia: Genes and Beyond
|
Bruce A. Warden PharmD, BCPS-AQ Cardiology, Sergio Fazio MD, PhD and Michael D. Shapiro, DO |
8
Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment
|
Alan Chait, MD and Savitha Subramanian, MD |
9
Rare Genetic Disorders Altering Lipoproteins
|
Michael D. Shapiro, DO |
10
Lipodystrophy Syndromes: Presentation and Treatment
|
Baris Akinci, Melis Sahinoz and Elif Oral |
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS |
11
Dyslipidemia in Diabetes
|
Kenneth R. Feingold, MD |
12
Dyslipidemia in Chronic Kidney Disease
|
Lisa Tannock, MD |
13
Lipid and Lipoprotein Metabolism in Liver Disease
|
David E. Cohen MD, PhD and Kathleen E. Corey MD MPH, MMSc |
14
The Effect of Endocrine Disorders on Lipids and Lipoproteins
|
Kenneth R. Feingold, MD, Eliot A. Brinton, MD, FAHA, FNLA and Carl Grunfeld, MD, PhD |
15
The Effect of Inflammation and Infection on Lipids and Lipoproteins
|
Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD |
16
Lipid Disorders In People With HIV
|
Sudipa Sarkar, MD, MSCI and Todd T. Brown MD, PhD |
17
Lipid and Lipoprotein Levels in Patients with Covid-19 Infections
|
Kenneth R. Feingold, MD |
18
Medication Induced Changes in Lipid and Lipoproteins
|
Megan Herink, Pharm.D., BCPS and Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS. |
19
Obesity and Dyslipidemia
|
Kenneth R. Feingold, MD |
20
Management of Dyslipidemia in the Elderly
|
Elani Streja, Ph.D. and Dan Streja, MD, FRCPC, FACP, FACE, |
21
Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels
|
Sarah B. Grimes, MD and Robert Wild, MD, MPH, PhD |
TREATMENT |
22
Approach to the Patient with Dyslipidemia
|
Kenneth R. Feingold, MD |
23
Lifestyle Changes: Effect of Diet, Exercise, Functional Food, and Obesity Treatment, on Lipids and Lipoproteins
|
Byambaa Enkhmaa, MD, PhD, MAS, Prasanth Surampudi, MD, PhD, Erdembileg Anuurad, MD, PhD, MAS and Lars Berglund, MD, PhD |
24
Cholesterol Lowering Drugs
|
Kenneth R. Feingold, MD |
25
Triglyceride Lowering Drugs
|
Kenneth R. Feingold, MD |
26
Lipoprotein Apheresis
|
Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD |
PEDIATRIC LIPIDOLOGY |
BACKGROUND |
27
Is Atherosclerosis a Pediatric Disease
|
Don P. Wilson, MD, FNLA |
28
Fetal and Neonatal Cholesterol Metabolism
|
Laura Woollett and James E Heubi |
29
Non-Invasive Techniques In Pediatric Dyslipidemia
|
Damon B. Dixon, MD |
30
Principles of Genetic Testing for Dyslipidemia in Children
|
Luke Hamilton, MS, Ariel Brautbar, MD and Don P. Wilson, MD, FNLA |
31
Genetics and Dyslipidemia
|
Nivedita Patni, MD, Zahid Ahmad, MD and Don P. Wilson, MD, FNLA |
SCREENING AND GUIDELINES |
32
Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents
|
Stephen R. Daniels, MD, PhD |
33
Lipid Screening in Youth
|
Lindsay Eilers, MD and Justin P. Zachariah MD MPH |
HYPERCHOLESTEROLEMIA |
34
Familial Hypercholesterolemia
|
Amy E. Levenson, MD and Sarah D. de Ferranti, MD, MPH |
35
Lysosomal Acid Lipase Deficiency
|
Don P. Wilson, MD, FNLA and Nivedita Patni, MD |
36
Sitosterolemia in the Pediatric Population
|
Ann Liebeskind, MD, Amy L. Peterson, MD and Don P. Wilson, MD, FNLA |
37
Cerebrotendinous Xanthomatosis
|
Nivedita Patni, MD and Don P. Wilson, MD, FNLA |
38
Lipoprotein (a) in Youth
|
Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD |
HYPERTRIGLYCERIDEMIA |
39
Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents
|
Amy S. Shah, MD MS. and Don P. Wilson, MD, FNLA |
40
Secondary Hypertriglyceridemia
|
Irwin Benuck, MD, PhD, Don P. Wilson, MD, FNLA and Catherine J. McNeal, MD, PhD |
TREATMENT |
41
Combined Dyslipidemia in Children and Adolescents
|
Rae-Ellen W. Kavey, MD, MPH. |
42
Nutritional Management of Pediatric Dyslipidemia
|
Lauren A. Williams, MCN, RD and Don P. Wilson, MD, FNLA |
43
Use of Lipid Lowering Medications in Youth
|
Melissa L Miller, PharmD, Chanin C Wright, PharmD. and Brandi Rodriguez, PharmD |
44
A Clinical Approach to Aggressive Treatment of Children with Severe Hypertriglyceridemia
|
Alejandro De La Torre, MD, Luke Hamilton, MS and Don P. Wilson, MD, FNLA |